Annual Drug Patent Expirations for EVRYSDI
Evrysdi is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has one hundred and six patent family members in thirty-nine countries.
The generic ingredient in EVRYSDI is risdiplam. One supplier is listed for this compound. Additional details are available on the risdiplam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com